RNA 8-K 2026-07-14

Atrium Therapeutics, Inc. (RNA) 8-K dated 2026-07-14 — accession 0001193125-26-303393. This URL is the filing, not the RNA hub.

Atrium Therapeutics, Inc. (RNA) is a biotechnology company listed on NASDAQ.

Atrium Therapeutics, Inc. filed a 8-K on 2026-07-14. Accession 0001193125-26-303393.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.

Not investment advice. The RNA SEC hub lists recent forms. The stock page is the research view.